<DOC>
	<DOCNO>NCT02881268</DOCNO>
	<brief_summary>Open-label , non-randomized , prospective , single center , observational , translational study</brief_summary>
	<brief_title>Study Immunosuppression Biomarkers Acquired Patients Hospitalized Intensive Care Unit</brief_title>
	<detailed_description>The aim trial study immunosuppression biomarkers patient hospitalize intensive care unit comparison non-septic patient . Prevalence immunosuppression acquire intensive care unit study patient likely develop nosocomial infection early identify</detailed_description>
	<criteria>Patient old 18 year old Patient hospitalize intensive care unit reason Patient infection start less 5 day admission Patient mechanical ventilation Patient arterial catheter invasive monitoring blood pressure Patient inform study protocol approve participate . Patients hospitalize severe bacterial infection ( severe sepsis septic shock ) Patient hospitalize noninfectious disease Pregnancy Advanced immunosuppression define proved humoral cellular impairment continuous administration steroid dose since one month hospitalization , transplantation , radiotherapy chemotherapy precede year Initiation immunosuppressive therapy chemotherapy , cyclophosphamide high dose corticotherapy ( &gt; 0.5mg/kg/day )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>